Similar articles

• Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients.

  Delgado JF, Torres J, José Ruiz-Cano M, Sánchez V, Escribano P, Borruel S, María Cortina J, de la Calzada CS. Delgado JF, et al. J Heart Lung Transplant. 2006 Sep;25(9):1171-4. doi: 10.1016/j.healun.2006.05.013. J Heart Lung Transplant. 2006. PMID: 16962483
• Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.

  Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E. Garrean S, et al. Clin Transplant. 2005 Oct;19(5):698-703. doi: 10.1111/j.1399-0012.2005.00356.x. Clin Transplant. 2005. PMID: 16146565
• Reversible sirolimus-associated pneumonitis after heart transplantation.

  Hamour IM, Mittal TK, Bell AD, Banner NR. Hamour IM, et al. J Heart Lung Transplant. 2006 Feb;25(2):241-4. doi: 10.1016/j.healun.2005.08.022. Epub 2005 Dec 20. J Heart Lung Transplant. 2006. PMID: 16446228
• Interstitial pneumonitis in the transplant patient: consider sirolimus-associated pulmonary toxicity.

  Feagans J, Victor D, Moehlen M, Florman SS, Regenstein F, Balart LA, Joshi S, Killackey MT, Slakey DP, Paramesh AS. Feagans J, et al. J La State Med Soc. 2009 May-Jun;161(3):166, 168-72. J La State Med Soc. 2009. PMID: 19772040 Review.
• Considerations in sirolimus use in the early and late post-transplant periods.

  Patel SJ, Elliott EN, Knight RJ, Gaber LW, Gaber AO. Patel SJ, et al. Expert Opin Drug Saf. 2009 Jul;8(4):421-34. doi: 10.1517/14740330903037156. Expert Opin Drug Saf. 2009. PMID: 19522662 Review.